Bond Gilead Sciences 5.1% ( US375558CC55 ) in USD
| Issuer | Gilead Sciences | ||||||||||||||
| Market price | |||||||||||||||
| Country | United States
|
||||||||||||||
| ISIN code |
US375558CC55 ( in USD )
|
||||||||||||||
| Interest rate | 5.1% per year ( payment 2 times a year) | ||||||||||||||
| Maturity | 15/06/2035 | ||||||||||||||
|
Prospectus brochure in PDF format |
|||||||||||||||
| Minimal amount | / | ||||||||||||||
| Total amount | / | ||||||||||||||
| Cusip | 375558CC5 | ||||||||||||||
| Standard & Poor's ( S&P ) rating | A- ( Upper medium grade - Investment-grade ) | ||||||||||||||
| Moody's rating | A3 ( Upper medium grade - Investment-grade ) | ||||||||||||||
| Next Coupon | 15/12/2026 ( In 111 days ) | ||||||||||||||
| Detailed description |
Gilead Sciences is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, primarily in HIV/AIDS, viral hepatitis, and oncology. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558CC55, pays a coupon of 5.1% per year. The coupons are paid 2 times per year and the Bond maturity is 15/06/2035 The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558CC55, was rated A3 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Gilead Sciences ( United States ) , in USD, with the ISIN code US375558CC55, was rated A- ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||||||
| |||||||||||||||
Français
Italiano
United States